A busy judge has pushed the parties in a class action against agrochemical giant Monsanto to split the trial to focus first on the question of whether the company’s Roundup weed killer causes cancer so that he can avoid writing a judgment of âhundreds and hundredsâ of pages.
A law firm has questioned an âinnovativeâ funding model proposed by its rival in a contest to run a class action against Jaguar Land Rover over allegedly defective diesel filters in its vehicles.
A class action against Bayer over its Essure device has won court approval to add new allegations, including that the contraceptive caused sexual dysfunction, with a judge finding the new claims could not have taken the German drug maker by surprise.
A class action by property owners against the manufacturer and supplier of alleged combustible cladding has lost a bid for sales figures to estimate the value of their claims as the parties head into settlement negotiations next month.
A class action filed on behalf of women injured by allegedly defective pelvic mesh products has reached a settlement with the insurer of defunct device maker TFS Manufacturing.
Sixteen law firms and accounting firms have thrown their hat in the ring to administer a $300 million settlement in two class actions against Johnson & Johnson over pelvic mesh devices that injured thousands of women.
Hyundai and Kia have been hit with new class actions alleging the Korean car makers knew of engine issues in cars sold in Australia as far back as 2015.
A second class action has been brought against Jaguar Land Rover over alleged defective diesel filters in its vehicles, and the law firms running the two cases have been given until the end of the month to reach a deal to avoid a court showdown.
A judge has opened the administration of a $300 million settlement in a pelvic mesh class action to a competitive bidding process, shortly after another judge said law firms were not uniquely qualified to distribute class action spoils.
A judge has found the applicant in a dismissed class action against animal health giant Zoetis is liable for the company’s defence costs in the case centering on alleged serious side effects of horse vaccine Equivac.